Get Insider Positions by Ticker

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Adds context beyond readOnlyHint: explains it returns lifetime aggregates of cost/value and source (Form 4). No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Two sentences, front-loaded with core purpose, second sentence adds source. No fluff.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given output schema exists and the tool has only one parameter, the description sufficiently explains purpose, source, and output nature. No missing critical info.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with a clear description for 'ticker'. Description repeats 'given ticker' but adds no extra meaning. Baseline 3 is appropriate.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

Clearly states it gets 'per-insider lifetime position aggregates' for a given ticker, differentiating from sibling tools like get_insider_positions and get_insider_transactions. Verb and resource are specific.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

Implies usage for aggregate insider positions per ticker, but no explicit when-not-to-use or alternative tools mentioned. Context from 'Derived from Form 4' helps, but guidance is minimal.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.